TNF and rheumatoid arthritis: It was initially approved for low-grade or follicular non-Hodgkin’s lymphoma and, more recently, for the treatment of rheumatoid arthritis (RA) unresponsive to anti-TNF-α therapies (Grillo-López et al, 1999; Edwards and Cambridge, 2006; Taylor and Lindorfer, 2007).